Application of circulating tumor DNA in prospective clinical oncology trials – standardization of preanalytical conditions

Circulating tumor DNA (ctDNA) has emerged as a potential new biomarker with diagnostic, predictive, and prognostic applications for various solid tumor types. Before beginning large prospective clinical trials to prove the added value of utilizing ctDNA in clinical practice, it is essential to inves...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: van Dessel, Lisanne F., Beije, Nick, Helmijr, Jean C.A., Vitale, Silvia R., Kraan, Jaco, Look, Maxime P., de Wit, Ronald, Sleijfer, Stefan, Jansen, Maurice P.H.M., Martens, John W.M., Lolkema, Martijn P.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527445/
https://ncbi.nlm.nih.gov/pubmed/28164427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados